Cargando…
Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
RATIONALE: Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a variable range of malignant potential. These neoplasms tend to have a slower growth rate than exocrine tumors and may remain undetecta...
Autores principales: | Lolli, Ivan, Stasi, Elisa, Fucilli, Fabio, Pirrelli, Michele, Armentano, Raffaele, Campanella, Giovanna, Lotesoriere, Claudio, Lorusso, Dionigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500045/ https://www.ncbi.nlm.nih.gov/pubmed/28658123 http://dx.doi.org/10.1097/MD.0000000000007273 |
Ejemplares similares
-
Primary lymph node gastrinoma: a case report and review of the literature
por: Cavalcanti, Elisabetta, et al.
Publicado: (2020) -
Nomogram for predicting survival of patients with metastatic nonfunctioning pancreatic neuroendocrine tumors: A SEER based study
por: Ge, Lina, et al.
Publicado: (2021) -
Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors: Case series
por: Müller, Christian, et al.
Publicado: (2022) -
Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study
por: Li, Gang, et al.
Publicado: (2020) -
Hemorrhagic disseminated intravascular coagulation after (177)Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report
por: Worbe, Noémie, et al.
Publicado: (2021)